The hospital costs of treating lung cancer in the United Kingdom

被引：29
|
作者：
Wolstenholme, JL
Whynes, DK [1 ]
机构：
[1] Univ Nottingham, Queens Med Ctr, Sch Med, Trent Inst Hlth Serv Res, Nottingham NG7 2UH, England
[2] Univ Nottingham, Dept Econ, Nottingham NG7 2RD, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷 / 1-2期
关键词：
cancer; costs; lung cancer;
D O I：
10.1038/sj.bjc.6690341
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A detailed patient-by-patient costing analysis, based on case records for 253 patients diagnosed in 1993, reveals that the mean 4-year diagnosis and management costs amounted to pound 6150 and pound 5668 for non-small cell and small cell lung cancer respectively. These costs are lower than those identified in Canadian studies, the difference being explained by the use of a simulated costing methodology in these studies, lower unit costs and less aggressive interventions.
引用
收藏
页码：215 / 218
页数：4
相关论文
共 50 条
  • [41] The current hospital costs of treating hip fractures
    Lawrence, TM
    White, CT
    Wenn, R
    Moran, CG
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2005, 36 (01): : 88 - 91
  • [42] IMRT for treating lung cancer - our experience at Northampton General Hospital
    Vaidya, D.
    Acquah, H.
    Guinee, L.
    York, C.
    Whilde, N.
    Blackmore, A.
    Duggleby, S.
    Yusof, H.
    Jackson, A. H.
    Patil, R.
    Mak, C. I.
    Gore, A.
    LUNG CANCER, 2015, 87 : S51 - S52
  • [43] The health care costs of diabetic nephropathy in the United States and the United Kingdom
    Gordois, A
    Scuffham, P
    Shearer, A
    Oglesby, A
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2004, 18 (01) : 18 - 26
  • [44] The health care costs of diabetic nephropathy in the United States and the United Kingdom
    Gordois, A
    Scuffham, P
    Shearer, A
    Oglesby, A
    DIABETES, 2003, 52 : A185 - A186
  • [45] Comparative Performance of Lung Cancer Risk Models to Define Lung Screening Eligibility in the United Kingdom
    Robbins, H.
    Alcala, K.
    Swerdlow, A.
    Schoemaker, M.
    Wareham, N.
    Key, T.
    Travis, R.
    Brennan, P.
    Crosbie, P.
    Callister, M.
    Baldwin, D.
    Landy, R.
    Johansson, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S480 - S480
  • [46] Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom
    Robbins, Hilary A.
    Alcala, Karine
    Swerdlow, Anthony J.
    Schoemaker, Minouk J.
    Wareham, Nick
    Travis, Ruth C.
    Crosbie, Philip A. J.
    Callister, Matthew
    Baldwin, David R.
    Landy, Rebecca
    Johansson, Mattias
    BRITISH JOURNAL OF CANCER, 2021, 124 (12) : 2026 - 2034
  • [47] Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom
    Hilary A. Robbins
    Karine Alcala
    Anthony J. Swerdlow
    Minouk J. Schoemaker
    Nick Wareham
    Ruth C. Travis
    Philip A. J. Crosbie
    Matthew Callister
    David R. Baldwin
    Rebecca Landy
    Mattias Johansson
    British Journal of Cancer, 2021, 124 : 2026 - 2034
  • [48] THE INCIDENCE, RESOURCE UTILIZATION AND FINANCIAL COSTS OF TREATING CHILDREN WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN THE UNITED KINGDOM (UK)
    Holden, S. E.
    Setyawan, J.
    Coghill, D.
    Hodgkins, P.
    Currie, C. J.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [49] Some costs and benefits of price stability in the United Kingdom
    Bakhshi, H
    Haldane, AG
    Hatch, N
    COSTS AND BENEFITS OF PRICE STABILITY, 1999, : 133 - 198
  • [50] COSTS AND BENEFITS OF ADULT RETRAINING IN UNITED-KINGDOM
    ZIDERMAN, A
    ECONOMICA, 1969, 36 (144) : 363 - 376
12345